Sales Concentration in The Cleansing Balm
First written in FY2020. 4 of 7 entries say "Mitigated", first in FY2021. Latest entry: FY2026.
The whole theme swung hardest in 2024: 13 of 48 companies on the "Worse" side.
29 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The “DUO” brand accounted for approximately 58% of sales in the fiscal year.」
The DUO brand accounted for approximately 58% of sales, indicating a concentration in a specific brand at roughly the same level as in the previous fiscal year. - FY2025MitigatedAnnual report
「The DUO brand accounted for approximately 58% of sales in the current fiscal year.」
DUO's share of sales fell from approximately 65% in the previous fiscal year to approximately 58%, with diversification toward CANADEL, Clayence, the Recovery business and other areas. - FY2023MitigatedAnnual report
「However, the DUO brand, the Group's flagship brand, still accounted for a high 65% of sales in the current fiscal year, and the Company recognizes that it needs to increase sales of other brands to stabilize management.」
DUO's share of sales fell from 82% in the previous fiscal year to 65%, numerically easing sales concentration risk as CANADEL, Clayence and other businesses grew. However, concentration in the largest brand remains. - FY2022WorsenedAnnual report
「However, the DUO brand, the Group's flagship brand, still accounted for a high 82% of sales in the current fiscal year, and the Company recognizes that it needs to increase sales of other brands to stabilize management.」
DUO's share of sales rose from 80.3% in the previous fiscal year to 82%, indicating a numerical deterioration in concentration risk. - FY2022-Q3MitigatedAnnual report
「In April, approximately 120,000 new subscription customers were acquired across all brands through direct-to-consumer channels, and acquisition remained at a high level. A notable change from the past is that acquisition has shifted from being centered on DUO to being distributed across multiple brands, steadily strengthening business stability.」
It describes progress toward mitigating sales concentration in specific products and brands through greater diversification of customer acquisition across multiple brands. - FY2021MitigatedAnnual report
「The Cleansing Balm accounted for a high 80.3% of sales in the current fiscal year, and the Company recognizes that it needs to increase sales of other products to stabilize management.」
Although the risk of sales concentration remains high, the ratio declined from 84.4% in the previous fiscal year to 80.3%, and the Company is strengthening other products and new brands. - FY2020First statedAnnual report
「The Cleansing Balm accounted for a high 84.4% of sales in the fiscal year ended July 2020, and the Company recognizes that it needs to increase sales of other products to stabilize management.」
It plans to respond by planning new products and brands and increasing staffing in the product planning and development department.